An Exceedingly Rare Case of Liraglutide-Induced Liver Injury

Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes mellitus. We are reporting the second case of liraglutide-induced liver injury, with complete resolution of liver injury after discontinuation of the drug.

Detalles Bibliográficos
Autores principales: Parvataneni, Swetha, Ramachandran, Rajarajeshwari, Then, Eric, Grantham, Tyler, Gaduputi, Vinaya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405313/
https://www.ncbi.nlm.nih.gov/pubmed/34471551
http://dx.doi.org/10.1155/2021/6306149
_version_ 1783746306393505792
author Parvataneni, Swetha
Ramachandran, Rajarajeshwari
Then, Eric
Grantham, Tyler
Gaduputi, Vinaya
author_facet Parvataneni, Swetha
Ramachandran, Rajarajeshwari
Then, Eric
Grantham, Tyler
Gaduputi, Vinaya
author_sort Parvataneni, Swetha
collection PubMed
description Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes mellitus. We are reporting the second case of liraglutide-induced liver injury, with complete resolution of liver injury after discontinuation of the drug.
format Online
Article
Text
id pubmed-8405313
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-84053132021-08-31 An Exceedingly Rare Case of Liraglutide-Induced Liver Injury Parvataneni, Swetha Ramachandran, Rajarajeshwari Then, Eric Grantham, Tyler Gaduputi, Vinaya Case Rep Gastrointest Med Case Report Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used for the treatment of type 2 diabetes mellitus. We are reporting the second case of liraglutide-induced liver injury, with complete resolution of liver injury after discontinuation of the drug. Hindawi 2021-08-23 /pmc/articles/PMC8405313/ /pubmed/34471551 http://dx.doi.org/10.1155/2021/6306149 Text en Copyright © 2021 Swetha Parvataneni et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Parvataneni, Swetha
Ramachandran, Rajarajeshwari
Then, Eric
Grantham, Tyler
Gaduputi, Vinaya
An Exceedingly Rare Case of Liraglutide-Induced Liver Injury
title An Exceedingly Rare Case of Liraglutide-Induced Liver Injury
title_full An Exceedingly Rare Case of Liraglutide-Induced Liver Injury
title_fullStr An Exceedingly Rare Case of Liraglutide-Induced Liver Injury
title_full_unstemmed An Exceedingly Rare Case of Liraglutide-Induced Liver Injury
title_short An Exceedingly Rare Case of Liraglutide-Induced Liver Injury
title_sort exceedingly rare case of liraglutide-induced liver injury
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8405313/
https://www.ncbi.nlm.nih.gov/pubmed/34471551
http://dx.doi.org/10.1155/2021/6306149
work_keys_str_mv AT parvataneniswetha anexceedinglyrarecaseofliraglutideinducedliverinjury
AT ramachandranrajarajeshwari anexceedinglyrarecaseofliraglutideinducedliverinjury
AT theneric anexceedinglyrarecaseofliraglutideinducedliverinjury
AT granthamtyler anexceedinglyrarecaseofliraglutideinducedliverinjury
AT gaduputivinaya anexceedinglyrarecaseofliraglutideinducedliverinjury
AT parvataneniswetha exceedinglyrarecaseofliraglutideinducedliverinjury
AT ramachandranrajarajeshwari exceedinglyrarecaseofliraglutideinducedliverinjury
AT theneric exceedinglyrarecaseofliraglutideinducedliverinjury
AT granthamtyler exceedinglyrarecaseofliraglutideinducedliverinjury
AT gaduputivinaya exceedinglyrarecaseofliraglutideinducedliverinjury

Ejemplares similares